326 related articles for article (PubMed ID: 28114223)
1. Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
Sheikhbahaei S; Jones CS; Porter KK; Rowe SP; Gorin MA; Baras AS; Pierorazio PM; Ball MW; Higuchi T; Johnson PT; Solnes LB; Epstein JI; Allaf ME; Javadi MS
Clin Nucl Med; 2017 Apr; 42(4):e188-e193. PubMed ID: 28114223
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of
Reynolds AM; Porter KK
Curr Urol Rep; 2017 Sep; 18(11):86. PubMed ID: 28900880
[TBL] [Abstract][Full Text] [Related]
3. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
4. Use of quantitative SPECT/CT reconstruction in
Jones KM; Solnes LB; Rowe SP; Gorin MA; Sheikhbahaei S; Fung G; Frey EC; Allaf ME; Du Y; Javadi MS
Ann Nucl Med; 2018 Feb; 32(2):87-93. PubMed ID: 29214562
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of
Parihar AS; Mhlanga J; Ronstrom C; Schmidt LR; Figenshau RS; Dehdashti F; Wahl RL
J Nucl Med; 2023 Jan; 64(1):90-95. PubMed ID: 35772963
[TBL] [Abstract][Full Text] [Related]
6. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Asi T; Tuncali MÇ; Tuncel M; Alkanat NEİ; Hazir B; Kösemehmetoğlu K; Baydar DE; Akdoğan B
Urol Oncol; 2020 Dec; 38(12):937.e11-937.e17. PubMed ID: 32859460
[TBL] [Abstract][Full Text] [Related]
7. 99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.
Ali AA; Sivathapandi T; Gupta R; Master VA; Marcus C
Clin Nucl Med; 2023 Aug; 48(8):e390-e392. PubMed ID: 37335313
[TBL] [Abstract][Full Text] [Related]
8. Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.
Rowe SP; Gorin MA; Gordetsky J; Ball MW; Pierorazio PM; Higuchi T; Epstein JI; Allaf ME; Javadi MS
Clin Nucl Med; 2015 Apr; 40(4):309-13. PubMed ID: 25608174
[TBL] [Abstract][Full Text] [Related]
9. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A
J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576
[TBL] [Abstract][Full Text] [Related]
10. The Role of
Basile G; Fallara G; Verri P; Uleri A; Chiti A; Gianolli L; Pepe G; Tedde A; Algaba F; Territo A; Sanguedolce F; Larcher A; Gallioli A; Palou J; Montorsi F; Capitanio U; Breda A
Eur Urol; 2024 Jan; 85(1):63-71. PubMed ID: 37673752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Large Renal Mass Using 99mTc-MIBI SPECT/CT in a Patient With Chronic Kidney Disease.
Rowe SP; Gorin MA; Javadi MS; Allaf ME
Clin Nucl Med; 2017 Mar; 42(3):e166-e167. PubMed ID: 28072625
[TBL] [Abstract][Full Text] [Related]
12.
Tzortzakakis A; Papathomas T; Gustafsson O; Gabrielson S; Trpkov K; Ekström-Ehn L; Arvanitis A; Holstensson M; Karlsson M; Kokaraki G; Axelsson R
Scand J Urol; 2022; 56(5-6):375-382. PubMed ID: 36065481
[TBL] [Abstract][Full Text] [Related]
13. 'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK:
Miller J; Campain N; Boydell AR; Warren H; Vito I; Neves J; Mumtaz F; Bex A; El-Shiekh S; Wagner T; Tran MGB
BJU Int; 2022 Jan; 129(1):28-31. PubMed ID: 34967994
[No Abstract] [Full Text] [Related]
14. 99m Tc-MIBI SPECT/CT in a Case of Renal Oncocytosis.
Zhao Q; Dong A; Zuo C; Yang B
Clin Nucl Med; 2023 Sep; 48(9):830-832. PubMed ID: 37486723
[TBL] [Abstract][Full Text] [Related]
15. Dual-Phase 99mTc-MIBI SPECT/CT in the Characterization of Enhancing Solid Renal Tumors: A Single-Institution Study of 147 Cases.
Zhu H; Yang B; Dong A; Ye H; Cheng C; Pan G; Zuo C
Clin Nucl Med; 2020 Oct; 45(10):765-770. PubMed ID: 32701813
[TBL] [Abstract][Full Text] [Related]
16. Use of
Almassi N; Gorin MA; Purysko AS; Rowe SP; Kaouk J; Allaf ME; Campbell SC; Rhee A
Urology; 2018 Mar; 113():206-208. PubMed ID: 29174943
[TBL] [Abstract][Full Text] [Related]
17. The value of
Sistani G; Bjazevic J; Kassam Z; Romsa J; Pautler S
Can Urol Assoc J; 2021 Jun; 15(6):197-201. PubMed ID: 33212002
[TBL] [Abstract][Full Text] [Related]
18. The role of molecular imaging in the characterization of renal masses.
Meyer AR; Allaf ME; Rowe SP; Gorin MA
Curr Opin Urol; 2018 Mar; 28(2):159-165. PubMed ID: 29319547
[TBL] [Abstract][Full Text] [Related]
19. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
20. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
